prx-115
Recombinant proteinexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 23, 2023 (NCT05745727)
Timeline
Indications
Studied for
Mechanism of action
- Urate oxidaseSupplementation
Urate oxidase supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07280156 | Phase 2 | Dec 31, 2025 | Protalix |
| NCT05745727 | Phase 1 | Mar 23, 2023 | New Zealand Clinical Research, Protalix |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Protalix | For profit | 2 | 2 | 2 | 2023 |
| New Zealand Clinical Research | For profit | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1